[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:bronchiolitis-obliterans-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":41,"states":42},"Bronchiolitis Obliterans Syndrome",5,4,[8,16,22,28,34],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05922761","BElumosudil for Bronchiolitis Obliterans Prevention\u002FTherapy (BEBOP)",[12],"Phase 2","RECRUITING","2026-08-26T02:18:08.005333Z","2026-05-05T02:43:29.642353Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06018766","LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.",[12],"2026-08-26T02:16:00.194860Z","2026-05-05T02:43:28.020443Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT05041140","Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment",[],"2026-08-26T02:15:40.343619Z","2026-05-13T02:55:06.280232Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT04604522","Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome",[],"2026-08-26T02:18:46.137046Z","2026-05-13T02:55:06.256284Z",{"nct_id":35,"title":36,"phases":37,"status":38,"updated_at":39,"content_modified":40},"NCT05250037","The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:09:30.306745Z","2026-05-13T02:55:06.297727Z",[],[43,47],{"state":44,"count":45,"slug":46},"California",3,"california",{"state":48,"count":45,"slug":49},"Texas","texas"]